º¹ºÎ¼ö¼ú ȯÀÚ¿¡¼ µ¦½ºÆÇÅ׳îÀÇ Àå¿îµ¿¿¡ ´ëÇÑ È¿°ú
The Effect of Dexpanthenol in Postoperative Patients
Ȳ¹Ì¸®, ±èÈï´ë, Á¶µ¿È£, ÇÑ¿ø°ï,
¼Ò¼Ó »ó¼¼Á¤º¸
Ȳ¹Ì¸® ( Hwang Mi-Ri )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ °ºÏ»ï¼ºº´¿ø ¿Ü°úÇб³½Ç
±èÈï´ë ( Kim Heung-Dae )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ °ºÏ»ï¼ºº´¿ø ¿Ü°úÇб³½Ç
Á¶µ¿È£ ( Cho Dong-Ho )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ °ºÏ»ï¼ºº´¿ø ¿Ü°úÇб³½Ç
ÇÑ¿ø°ï ( Han Won-Kon )
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ °ºÏ»ï¼ºº´¿ø ¿Ü°úÇб³½Ç
KMID : 0356720070230020071
Abstract
Purpose: The purpose of this study was to compare the efficacy of dexpanthenol in postoperative patients. Dexpanthenol, the alcohol derivative of pantothenic acid, is believed to be a precursor of acetylcholine through its incorporation into coenzyme-A.
Methods:From June 2005 to December 2005, 130 curative abdominal surgery, which were divided into a dexpanthenol group with 65 patients and a control group with 65 patients, were prospectively and randomly studied for recovery of bowel motility.
Results: No significant difference was found between the two groups as to incidence of postoperative ileus (16.9% vs. 15.4%, P=0.081), the time to flatus (77.2¡¾38.4 vs. 77.9¡¾31.9 hours, P=0.90), the time to defecation (5.3¡¾2.7 vs. 5.1¡¾2.6 days, P=0.77), the time to resumption of meals (7.9¡¾4.0 vs. 8.9¡¾4.2 days, P=0.17), and the duration of hospital stay (16.4¡¾7.8 vs. 17.9¡¾11.5 days, P=0.39).
Conclusion: Since no differences in the postoperative bowel motility were observed between the two groups, dexpanthenol is not recommended for general surgical use. J Korean Soc Coloproctol 2007;23:71-74
Å°¿öµå
µ¦½ºÆÇÅ׳î;¼ú ÈÄ À帶ºñ
Dexpanthenol;Postoperative ileus
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸